(Q34097173)

31 July 2017

1 reference

title

Melatonin agonists and insomnia (English)

1 reference

31 July 2017

0 references

0 references

Shantha M. W. Rajaratnam

series ordinal

2

object named as

Shantha M W Rajaratnam

1 reference

31 July 2017

Sally A Ferguson

1

0 references

Drew Dawson

object named as

Drew Dawson

series ordinal

3

0 references

publication date

1 February 2010

1 reference

Expert Review of Neurotherapeutics: a key contribution to decision making in the treatment of neurologic and neuropsychiatric disorders

31 July 2017

1 reference

31 July 2017

10

1 reference

31 July 2017

2

1 reference

31 July 2017

305-318

1 reference

Cloning and characterization of a mammalian melatonin receptor that mediates reproductive and circadian responses

31 July 2017

1 reference

Let there be sleep--on time

21 January 2018

1 reference

Persistence of circadian rhythmicity in a mammalian hypothalamic "island" containing the suprachiasmatic nucleus

21 January 2018

1 reference

Minireview: The circadian clockwork of the suprachiasmatic nuclei--analysis of a cellular oscillator that drives endocrine rhythms

21 January 2018

1 reference

Life's 24-hour clock: molecular control of circadian rhythms in animal cells

21 January 2018

1 reference

Keeping time with the human genome.

21 January 2018

1 reference

Intrinsic near-24-h pacemaker period determines limits of circadian entrainment to a weak synchronizer in humans

21 January 2018

1 reference

Chronobiotics--drugs that shift rhythms

21 January 2018

1 reference

Melatonin as a chronobiotic.

21 January 2018

1 reference

Melatonin receptors step into the light: cloning and classification of subtypes

21 January 2018

1 reference

Melatonin receptors: role on sleep and circadian rhythm regulation

21 January 2018

1 reference

Melatonin agonist tasimelteon (VEC-162) for transient insomnia after sleep-time shift: two randomised controlled multicentre trials.

21 January 2018

1 reference

Neurochemical properties of ramelteon (TAK-375), a selective MT1/MT2 receptor agonist

21 January 2018

1 reference

Effect of MT1 melatonin receptor deletion on melatonin-mediated phase shift of circadian rhythms in the C57BL/6 mouse

21 January 2018

1 reference

Circadian entrainment and phase shifting in mammals with melatonin

21 January 2018

1 reference

The brain's master circadian clock: implications and opportunities for therapy of sleep disorders

21 January 2018

1 reference

A three pulse phase response curve to three milligrams of melatonin in humans

21 January 2018

1 reference

Acute phase-shifting effects of melatonin associated with suppression of core body temperature in humans.

21 January 2018

1 reference

Melatonin phase-shifts human circadian rhythms with no evidence of changes in the duration of endogenous melatonin secretion or the 24-hour production of reproductive hormones

21 January 2018

1 reference

Human circadian rhythms: physiological and therapeutic relevance of light and melatonin

21 January 2018

1 reference

Reentrainment of Rat Circadian Activity Rhythms: Effects of Melatonin

21 January 2018

1 reference

Ramelteon (TAK-375) accelerates reentrainment of circadian rhythm after a phase advance of the light-dark cycle in rats

21 January 2018

1 reference

Preclinical pharmacokinetics and metabolism of BMS-214778, a novel melatonin receptor agonist

21 January 2018

1 reference

Successful use of S20098 and melatonin in an animal model of delayed sleep-phase syndrome (DSPS).

21 January 2018

1 reference

Phase-shifts of 24-h rhythms of hormonal release and body temperature following early evening administration of the melatonin agonist agomelatine in healthy older men.

21 January 2018

1 reference

Importance and relevance of melatonin to human biological rhythms

21 January 2018

1 reference

Melatonin as a hypnotic: pro.

21 January 2018

1 reference

Reduced sleep efficiency in cervical spinal cord injury; association with abolished night time melatonin secretion.

21 January 2018

1 reference

Changes in sleepiness and body temperature precede nocturnal sleep onset: evidence from a polysomnographic study in young men.

21 January 2018

1 reference

Thermoregulation as a sleep signalling system

21 January 2018

1 reference

Warm feet promote the rapid onset of sleep.

21 January 2018

1 reference

Daytime melatonin and temazepam in young adult humans: equivalent effects on sleep latency and body temperatures.

21 January 2018

1 reference

More than a marker: interaction between the circadian regulation of temperature and sleep, age-related changes, and treatment possibilities

21 January 2018

1 reference

Melatonin and melatonergic drugs on sleep: possible mechanisms of action

21 January 2018

1 reference

Melatonin as a hypnotic: con.

21 January 2018

1 reference

A practical approach to circadian rhythm sleep disorders

21 January 2018

1 reference

Melatonin and its agonists: an update

21 January 2018

1 reference

Peripheral heat loss: a predictor of the hypothermic response to melatonin administration in young and older women.

21 January 2018

1 reference

Effect of sustained nocturnal transbuccal melatonin administration on sleep and temperature in elderly insomniacs.

21 January 2018

1 reference

Improvement of sleep quality in elderly people by controlled-release melatonin.

21 January 2018

1 reference

Effects of prolonged-release melatonin, zolpidem, and their combination on psychomotor functions, memory recall, and driving skills in healthy middle aged and elderly volunteers

21 January 2018

1 reference

Ultrashort sleep-waking schedule. III. 'Gates' and 'forbidden zones' for sleep.

21 January 2018

1 reference

Melatonin advances the circadian timing of EEG sleep and directly facilitates sleep without altering its duration in extended sleep opportunities in humans

21 January 2018

1 reference

Efficacy and safety of exogenous melatonin for secondary sleep disorders and sleep disorders accompanying sleep restriction: meta-analysis

21 January 2018

1 reference

The efficacy and safety of exogenous melatonin for primary sleep disorders. A meta-analysis

21 January 2018

1 reference

Melatonin, sleep, and circadian rhythms: rationale for development of specific melatonin agonists

21 January 2018

1 reference

Effects of ramelteon (TAK-375) on nocturnal sleep in freely moving monkeys

21 January 2018

1 reference

Influence of the novel antidepressant and melatonin agonist/serotonin2C receptor antagonist, agomelatine, on the rat sleep-wake cycle architecture

21 January 2018

1 reference

The effects of ramelteon in a first-night model of transient insomnia

21 January 2018

1 reference

Melatonin Administration to Blind People: Phase Advances and Entrainment

21 January 2018

1 reference

Melatonin stabilises sleep onset time in a blind man without entrainment of cortisol or temperature rhythms

21 January 2018

1 reference

Effects of melatonin administration on daytime sleep after simulated night shift work

21 January 2018

1 reference

Delayed sleep phase syndrome response to melatonin

21 January 2018

1 reference

Efficacy of melatonin treatment in jet lag, shift work, and blindness.

21 January 2018

1 reference

Delayed sleep phase syndrome: A placebo-controlled cross-over study on the effects of melatonin administered five hours before the individual dim light melatonin onset.

21 January 2018

1 reference

Comparative study to determine the optimal melatonin dosage form for the alleviation of jet lag.

21 January 2018

1 reference

Does melatonin improve sleep? Efficacy of melatonin

21 January 2018

1 reference

Evaluating the role of melatonin in the long-term treatment of delayed sleep phase syndrome (DSPS).

21 January 2018

1 reference

Melatonin administration can entrain the free-running circadian system of blind subjects

21 January 2018

1 reference

Entrainment of free-running circadian rhythms by melatonin in blind people

21 January 2018

1 reference

Prolonged-release melatonin improves sleep quality and morning alertness in insomnia patients aged 55 years and older and has no withdrawal effects

21 January 2018

1 reference

Efficacy and clinical safety of ramelteon: an evidence-based review

21 January 2018

1 reference

An efficacy, safety, and dose-response study of Ramelteon in patients with chronic primary insomnia

21 January 2018

1 reference

Effects of ramelteon on patient-reported sleep latency in older adults with chronic insomnia.

21 January 2018

1 reference

A 2-night, 3-period, crossover study of ramelteon's efficacy and safety in older adults with chronic insomnia.

21 January 2018

1 reference

Efficacy and tolerability of indiplon in older adults with primary insomnia.

21 January 2018

1 reference

Ramelteon: a novel hypnotic lacking abuse liability and sedative adverse effects.

21 January 2018

1 reference

Antidepressant action of agomelatine (S 20098) in a transgenic mouse model

21 January 2018

1 reference

Determination of the dose of agomelatine, a melatoninergic agonist and selective 5-HT(2C) antagonist, in the treatment of major depressive disorder: a placebo-controlled dose range study

21 January 2018

1 reference

Placebo-controlled trial of agomelatine in the treatment of major depressive disorder

21 January 2018

1 reference

Improvement in subjective sleep in major depressive disorder with a novel antidepressant, agomelatine: randomized, double-blind comparison with venlafaxine

21 January 2018

1 reference

Agomelatine: a novel mechanism of antidepressant action involving the melatonergic and the serotonergic system.

21 January 2018

1 reference

Efficacy and tolerance profile of agomelatine and practical use in depressed patients

21 January 2018

1 reference

Effect of agomelatine in the chronic mild stress model of depression in the rat.

21 January 2018

1 reference

Melatonin and Melatonin Analogues

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERN.10.1

1 reference

31 July 2017

1 reference

PubMed ID

20136385